Posted by Michael Wonder on 06 Mar 2025
Idebenone for the treatment of patients 12 years of age and older with visual impairment in Leber’s hereditary optic neuropathy (updated draft guidance)
5 March 2025 - NICE has produced additional draft guidance on the use of idebenone in the NHS in England.
Idebenone remains not recommended for the treatment of patients 12 years of age and older with visual impairment associated with Leber’s hereditary optic neuropathy.
